Categories: ConferencesEvents

Highlights of SABCS21 held in Seattle, WA

The Binaytara Foundation hosted the live, in-person conference, Highlights of San Antonio Breast Cancer Symposium on January 29, 2022 at the Grand Hyatt, Seattle. Dr. Hope Rugo of University of California San Francisco (UCSF), Dr. Christos Vaklavas of the University of Utah, Dr. Fenting Yan of Swedish Cancer Institute in Seattle, and several other breast oncologists from the pacific northwest as well as oncology industry professionals attended this accredited continuing medical education (CME) in-person. All faculty from the Seattle Cancer Care Alliance participated virtually.

Pictures from the SABCS Highlights in Seattle

The live meeting has been recorded and is available as a self-paced enduring activity on our education portal. All self-paced activities provided by the Binaytara Foundation offer continuing education credits and are provided free of cost to any healthcare provider in the world who is not employed by an ACCME defined ineligible company. Employees of an ineligible company can participate in these activities free of cost if they registered and paid for the live meeting associated with the enduring contents.

Based on the identified educational needs, the Binaytara Foundation plans and implements educational activities that are relevant for our target population. In 2021, we provided continuing education to 700+ healthcare providers through our in-person and online platforms.

 

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

7 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

7 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

7 months ago